Effect of Aging on A1C Levels in Individuals Without Diabetes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Although glycemic levels are known to rise with normal aging, the nondiabetic A1C range is not age specific. We examined whether A1C was associated with age in nondiabetic subjects and in subjects with normal glucose tolerance (NGT) in two population-based cohorts. RESEARCH DESIGN AND METHODS—We performed cross-sectional analyses of A1C across age categories in 2,473 nondiabetic participants of the Framingham Offspring Study (FOS) and in 3,270 nondiabetic participants from the National Health and Nutrition Examination Survey (NHANES) 2001–2004. In FOS, we examined A1C by age in a subset with NGT, i.e., after excluding those with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). Multivariate analyses were performed, adjusting for sex, BMI, fasting glucose, and 2-h postload glucose values. RESULTS—In the FOS and NHANES cohorts, A1C levels were positively associated with age in nondiabetic subjects. Linear regression revealed 0.014- and 0.010-unit increases in A1C per year in the nondiabetic FOS and NHANES populations, respectively. The 97.5th percentiles for A1C were 6.0% and 5.6% for nondiabetic individuals aged <40 years in FOS and NHANES, respectively, compared with 6.6% and 6.2% for individuals aged ≥70 years (Ptrend < 0.001). The association of A1C with age was similar when restricted to the subset of FOS subjects with NGT and after adjustments for sex, BMI, fasting glucose, and 2-h postload glucose values. CONCLUSIONS—A1C levels are positively associated with age in nondiabetic populations even after exclusion of subjects with IFG and/or IGT. Further studies are needed to determine whether age-specific diagnostic and treatment criteria would be appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Published data show agerelated increases in HbA 1c values of approximately 0.1% per decade after age 30 years (224,225).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [224]
The cited source says what the claim attributes to it.
In the citing paper
“Population data show age-related increases in mean HbA 1c in people without diabetes of approximately 0.1% per decade after age 30 years (334,335).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [334]
In the citing paper
“Careful phenotyping of individuals with OGTT supports an increase in HbA 1c with age, even after removing from the study population patients with otherwise undiagnosed diabetes and persons with impaired glucose tolerance ( 224).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Self-citationAN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
The Clinical Information Value of the Glycosylated Hemoglobin Assay
Nathan, D. M., Singer, D. E., Hurxthal, K., & Goodson, J. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100602 · Cited by 706 · cited 1×
“A1C levels are used globally as an index of average glycemia over the preceding 8–12 weeks (3), as a marker for risk of development of diabetes complications, and to guide therapy (4).”
Self-citationDiabetes Control and Complications Trial (DCCT) Research Group (1996) · Diabetes · doi:10.2337/diab.45.10.1289 · Cited by 597
Epidemiologic studies utilizing surveys: accounting for the sampling design.
Korn, E. L., & Graubard, B. I. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.9.1166 · Cited by 490 · cited 2×
“We used the method of Korn and Graubard (28) to compute 95% CIs around the percentiles.”
MethodNathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006) · Diabetologia · doi:10.1007/s00125-006-0316-2 · Cited by 420
Self-citationDavidson, M. B. (1979) · Metabolism · doi:10.1016/0026-0495(79)90024-6 · Cited by 411 · cited 1×
“The prevalence of diabetes and impaired glucose homeostasis (impaired fasting glucose [IFG] and impaired glucose tolerance [IGT]) is increased among older individuals (1).”
The DCCT Research Group (1986) · Diabetes · doi:10.2337/diab.35.5.530 · Cited by 331
The burden and treatment of diabetes in elderly individuals in the U.S
Selvin, E., Coresh, J., & Brancati, F. L. (2006) · Diabetes Care · doi:10.2337/dc06-1058 · Cited by 261
Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Barr, R. G., Nathan, D. M., Meigs, J. B., & Singer, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-4-200208200-00011 · Cited by 215 · cited 1×
“The central role played by A1C in the management of diabetes (4) and possibly in its diagnosis (21) raises the question of whether there are age-related differences in A1C.”
Self-citationAltered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men
Matyka, K., Evans, M., Lomas, J., Cranston, I., Macdonald, I., & Amiel, S. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.2.135 · Cited by 195 · cited 2×
“If so, current A1C targets may be too stringent for older type 2 diabetic patients, who have an increased risk of hypoglycemia and medication side effects (22,23).”
Little, R. R. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.183 · Cited by 184
(1996) · Diabetes · doi:10.2337/diabetes.45.10.1289 · Cited by 165 · cited 1×
“Eventhough the association of A1C with complications is well established in individuals with diabetes (31) and in non-diabetic subjects (32,33), the clinical sig-nificance of increased A1C in the subset of older individuals who have no evidence of glucose intolerance is unknown.”
Relationship Between HbA1c Level and Peripheral Arterial Disease
Muntner, P., Wildman, R. P., Reynolds, K., DeSalvo, K. B., Chen, J., & Fonseca, V. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1981 · Cited by 158 · cited 1×
“diabetic subjects (32,33), the clinical sig-”
Simon, D., Senan, C., Garnier, P., Saint-Paul, M., & Papoz, L. (1989) · Diabetologia · doi:10.1007/bf00297451 · Cited by 104
Tracking of glycated hemoglobin in the original cohort of the framingham heart study
Meigs, J. B., Nathan, D. M., Cupples, L. A., Wilson, P. W. F., & Singer, D. E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00513-7 · Cited by 85
Self-citationLebovitz, H. E., Austin, M. M., Blonde, L., Davidson, J. A., Prato, S. D., Gavin, J. R., Handelsman, Y., Jellinger, P. S., Levy, P., Riddle, M. C., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.6 · Cited by 81
Yates, A. P., & Laing, I. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00644.x · Cited by 67
The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes
Kilpatrick, E. S., Dominiczak, M. H., & Small, M. (1996) · QJM · doi:10.1093/qjmed/89.4.307 · Cited by 65
Age and Sex Effects on HbA1c: A study in a healthy Chinese population
Yang, Y., Lu, F., Wu, J., & Chang, C. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.988 · Cited by 63 · cited 1×
“As in other studies (9), sex differences”
The Influence of Aging on Hemoglobin A1c(HbA1c)
Arnetz, B. B., Kallner, A., & Theorell, T. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.6.648 · Cited by 59
Executive Summary: Standards of Medical Care in Diabetes—2008
(2007) · Diabetes Care · doi:10.2337/dc08-s005 · Cited by 56
Glycosylation of Proteins: Lack of Influence of Aging
Kabadi, U. M. (1988) · Diabetes Care · doi:10.2337/diacare.11.5.429 · Cited by 46
Age does not influence levels of HbA1c in normal subject
Wiener, K., & Roberts, N. B. (1999) · QJM · doi:10.1093/qjmed/92.3.169 · Cited by 46
Effect of Aging on HbA1c in a Working Male Japanese Population
Hashimoto, Y., Futamura, A., & Ikushima, M. (1995) · Diabetes Care · doi:10.2337/diacare.18.10.1337 · Cited by 42 · cited 2×
“The age-related increase in A1C observed in our study is similar in magnitude to that in two previous studies: one in Japan (8) and one in a very small ( n (cid”
Nuttall, F. Q. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90165-8 · Cited by 36
Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
Greco, D., & Angileri, G. (2004) · PubMed · Cited by 34
Ko, G. T. C., Chan, J. C. N., Woo, J., Lau, E., Yeung, V. T. F., Chow, C. C., Li, J. K. Y., So, W. Y., Chan, W., & Cockram, C. S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199807)15:7<573::aid-dia614>3.0.co;2-m · Cited by 30 · cited 1×
“diabetic subjects (32,33), the clinical sig-”
Acceleration of hemoglobin glycation with aging
Nakashima, K., Nishizaki, O., & Andoh, Y. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90254-2 · Cited by 29 · cited 2×
“One such explanation may be changes in the rate of glycation associated with aging (12,13).”
Should Age and Sex Be Taken Into Account in the Determination of HbA1c Reference Range?
Carrera, T., Bonamusa, L., Almirall, L., & Navarro, J. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2193 · Cited by 24 · cited 2×
“Some have inadvertently included subjects with diabetes by not screening the populations for diabetes with fasting or postchallenge glucose levels (6,8,10).”
A different approach to analyzing age-related HbA1c values in non-diabetic subjects
Polneau, S. V., Lasserre, V., Fonfrède, M., Delattre, J., & Bénazeth, S. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.074 · Cited by 20
Glycosylated Haemoglobin in the Diagnosis of Diabetes Mellitus in Elderly People
Mulkerrin, E. C., Arnold, J. D., DEWAR, R., SYKES, D., Rees, A., & Pathy, M. (1992) · Age and Ageing · doi:10.1093/ageing/21.3.175 · Cited by 18
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
“Third, A1C levels appear to increase with age (50), but the extent of the change, whether it relates to factors other than glucose metabolism, and the effect of the age-related increases on the development of complications are not sufficiently clear to adopt age-specific values in a diagnostic scheme.”
Background(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
“Careful phenotyping of individuals with OGTT supports an increase in HbA1c with age, even after removing from the study population patients with otherwise undiagnosed diabetes and persons with impaired glucose tolerance (224).”
Self-citationDefinition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Metadata
- Authors
- Pani, L. N., Korenda, L., Meigs, J. B., Driver, C., Chamany, S., Fox, C. S., Sullivan, L., D’Agostino, R. B., & Nathan, D. M.
- Affiliations
- Harvard University (US)
- New York City Department of Health and Mental Hygiene (US)
- Brigham and Women's Hospital (US)
- Boston University (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 31
- Issue
- 10
- Pages
- 1991-1996
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2551641
- OpenAlex
- W2110911105
- Semantic Scholar
- 11ffcc83aa954d37e4717ba5c18f448b3782fbdb
- Cited by
- 378
- References
- 31
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 23 · 2023: 20 · 2022: 15 · 2021: 17 · 2020: 28 · 2019: 19 · 2018: 20 · 2017: 21 · 2016: 25 · 2015: 23 · 2014: 22 · 2013: 25 · 2012: 27
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- OpenBU (Boston University) (submittedVersion, cc-by-nc-nd)
- Funders
- American Diabetes Association
- GlaxoSmithKline
- Sanofi
- School of Medicine, Boston University (N01-HC25195)
- National Institutes of Health (n01hc25195-41-0-1, N01-HC 25195, Contract N01-HC-25195)
- National Heart, Lung, and Blood Institute (N01‐HC25195, N01-HC-025195)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK080140)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HbA1c, aging, normal glucose tolerance, non-diabetic adults, age-specific reference ranges, impaired fasting glucose, impaired glucose tolerance, Framingham Offspring Study, NHANES
- MeSH terms
- Adult, Aged, Aging, Chromatography, High Pressure Liquid, Cross-Sectional Studies, Diabetes Mellitus, Female, Health Surveys, Glycated Hemoglobin, Humans, Male, Middle Aged, Minority Groups, Reference Values, Glucose Intolerance, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.